Introduction: Pineal parenchymal tumors of intermediate differentiation (PPTIDs) are rare, pinealocyte-derived brain tumors that occur primarily in adults. The clinical prognosis fits somewhere between the benign pineocytoma and highly malignant pineoblastoma. There is very little published literature regarding this tumor in children and the existing pediatric information is enfolded with adult data in single-center reviews. The most common treatment recommendation for adults is aggressive resection, possibly followed by craniospinal irradiation (CSI) and/or chemotherapy. However, the adult literature is inconsistent, often contradictory, and does not address specific considerations in pediatric patients. To our knowledge, there are no papers specifically addressing the management and clinical considerations of PPTID in pediatric patients. As such, the optimal treatment strategy in children is unknown. Case Presentation: We describe the treatment of a 6-year-old child who presented with obstructive hydrocephalus from a PPTID. The child was treated with a partial tumor resection followed by localized proton beam radiation. He has been followed for 8 years. Clinically, he is doing well, and his most recent MRI shows negligible residual tumor with no sign of recurrence. Conclusions: Our case suggests safe resection followed by proton beam radiotherapy may be effective in treating children with this exceedingly rare entity. While further study is needed, this strategy may avoid unnecessary surgical risk and the consequences of CSI on the developing pediatric nervous system.

1.
Yu
T
,
Sun
X
,
Wang
J
,
Ren
X
,
Lin
N
,
Lin
S
.
Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis
.
J Neurol Neurosurg Psychiatry
.
2016
;
87
(
4
):
386
95
.
2.
Pfaff
E
,
Aichmüller
C
,
Sill
M
,
Stichel
D
,
Snuderl
M
,
Karajannis
MA
, et al
.
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations
.
Acta Neuropathol
.
2020
;
139
(
2
):
243
57
.
3.
Louis
DN
,
Ohgaki
H
,
Wiestler
OD
,
Cavenee
WK
,
Burger
PC
,
Jouvet
A
, et al
.
The 2007 WHO classification of tumours of the central nervous system
.
Acta Neuropathol
.
2007
;
114
(
2
):
97
109
.
4.
Schild
SE
,
Scheithauer
BW
,
Schomberg
PJ
,
Hook
CC
,
Kelly
PJ
,
Frick
L
, et al
.
Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects
.
Cancer
.
1993
;
72
(
3
):
870
80
.
5.
Sadashiva
N
,
Deora
H
,
Arumalla
K
,
Rao
S
,
Saini
J
,
Shukla
D
, et al
.
Pineal parenchymal tumor of intermediate differentiation (PPTID) and papillary tumor of pineal region (PTPR): a review
.
Neurol India
.
2021
;
69
(
5
):
1153
64
.
6.
Nam
JY
,
Gilbert
A
,
Cachia
D
,
Mandel
J
,
Fuller
GN
,
Penas-Prado
M
, et al
.
Pineal parenchymal tumor of intermediate differentiation: a single-institution experience
.
Neurooncol Pract
.
2020
;
7
(
6
):
613
9
.
7.
Raleigh
DR
,
Solomon
DA
,
Lloyd
SA
,
Lazar
A
,
Garcia
MA
,
Sneed
PK
, et al
.
Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome
.
Neuro Oncol
.
2017
;
19
(
1
):
78
88
.
8.
Merchant
TE
,
Hua
CH
,
Shukla
H
,
Ying
X
,
Nill
S
,
Oelfke
U
.
Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function
.
Pediatr Blood Cancer
.
2008
;
51
(
1
):
110
7
.
9.
Favero
G
,
Bonomini
F
,
Rezzani
R
.
Pineal gland tumors: a review
.
Cancers
.
2021
;
13
(
7
):
1547
.
10.
Jouvet
A
,
Saint-Pierre
G
,
Fauchon
F
,
Privat
K
,
Bouffet
E
,
Ruchoux
MM
, et al
.
Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases
.
Brain Pathol
.
2000
;
10
(
1
):
49
60
.
11.
Fèvre-Montange
M
,
Vasiljevic
A
,
Frappaz
D
,
Champier
J
,
Szathmari
A
,
Aubriot Lorton
MH
, et al
.
Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study
.
Neuropathol Appl Neurobiol
.
2012
;
38
(
1
):
87
94
.
12.
Fauchon
F
,
Jouvet
A
,
Paquis
P
,
Saint-Pierre
G
,
Mottolese
C
,
Ben Hassel
M
, et al
.
Parenchymal pineal tumors: a clinicopathological study of 76 cases
.
Int J Radiat Oncol Biol Phys
.
2000
;
46
(
4
):
959
68
.
13.
Liu
APY
,
Gudenas
B
,
Lin
T
,
Orr
BA
,
Klimo
P
Jr
,
Kumar
R
, et al
.
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials
.
Acta Neuropathol
.
2020
;
139
(
2
):
259
71
.
14.
Lee
JC
,
Mazor
T
,
Lao
R
,
Wan
E
,
Diallo
AB
,
Hill
NS
, et al
.
Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma
.
Acta Neuropathol
.
2019
;
137
(
5
):
851
4
.
15.
Mallick
S
,
Benson
R
,
Rath
GK
.
Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis
.
Radiother Oncol
.
2016
;
121
(
2
):
204
8
.
16.
Kerezoudis
P
,
Yolcu
YU
,
Laack
NN
,
Ruff
MW
,
Khatua
S
,
Daniels
DJ
, et al
.
Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: Insights from the National Cancer Database
.
Neurooncol Adv
.
2022
;
4
(
1
):
vdac057
.
17.
Lu
VM
,
Luther
EM
,
Eichberg
DG
,
Morell
AA
,
Shah
AH
,
Komotar
RJ
, et al
.
Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade
.
J Neuro Oncol
.
2021
;
155
(
2
):
165
72
.
18.
Ito
T
,
Kanno
H
,
Sato
K
,
Oikawa
M
,
Ozaki
Y
,
Nakamura
H
, et al
.
Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation
.
World Neurosurg
.
2014
;
81
(
5–6
):
783
9
.
19.
Webb
M
,
Johnson
DR
,
Mahajan
A
,
Brown
P
,
Neth
B
,
Kizilbash
SH
, et al
.
Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis
.
J Neuro Oncol
.
2022
;
160
(
2
):
527
34
.
20.
Bielle
F
,
Navarro
S
,
Bertrand
A
,
Cornu
P
,
Mazeron
JJ
,
Jouvet
A
, et al
.
Late dural relapse of a resected and irradiated pineal parenchymal tumor of intermediate differentiation
.
Clin Neuropathol
.
2014
;
33
(
6
):
424
7
.
21.
Farnia
B
,
Allen
PK
,
Brown
PD
,
Khatua
S
,
Levine
NB
,
Li
J
, et al
.
Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review
.
World Neurosurg
.
2014
;
82
(
6
):
1232
41
.
22.
Leroy
R
,
Benahmed
N
,
Hulstaert
F
,
Van Damme
N
,
De Ruysscher
D
.
Proton therapy in children: a systematic review of clinical effectiveness in 15 pediatric cancers
.
Int J Radiat Oncol Biol Phys
.
2016
;
95
(
1
):
267
78
.
23.
Pusztaszeri
M
,
Pica
A
,
Janzer
R
.
Pineal parenchymal tumors of intermediate differentiation in adults: case report and literature review
.
Neuropathology
.
2006
;
26
(
2
):
153
7
.
24.
Watanabe
T
,
Mizowaki
T
,
Arakawa
Y
,
Iizuka
Y
,
Ogura
K
,
Sakanaka
K
, et al
.
Pineal parenchymal tumor of intermediate differentiation: treatment outcomes of five cases
.
Mol Clin Oncol
.
2014
;
2
(
2
):
197
202
.
25.
Liu
C
,
Carmicheal
J
,
Baine
MJ
,
Zhang
C
.
Radiation therapy for pineal parenchymal tumor of intermediate differentiation: a case series and literature review
.
J Cent Nerv Syst Dis
.
2023
;
15
:
11795735231160036
.
26.
Kurisaka
M
,
Arisawa
M
,
Mori
T
,
Sakamoto
T
,
Seike
M
,
Mori
K
, et al
.
Combination chemotherapy (cisplatin, vinblastin) and low-dose irradiation in the treatment of pineal parenchymal cell tumors
.
Childs Nerv Syst
.
1998
;
14
(
10
):
564
9
.
You do not currently have access to this content.